Skip to main content
Frontiers in Bioengineering and Biotechnology logoLink to Frontiers in Bioengineering and Biotechnology
. 2023 May 4;11:1200532. doi: 10.3389/fbioe.2023.1200532

Corrigendum: Therapy of spinal cord injury by folic acid polyethylene glycol amine-modified zeolitic imidazole framework-8 nanoparticles targeted activated M/Ms

Qi Li 1, Yue Guo 1, Chang Xu 1, Jiachen Sun 1, Fanzhuo Zeng 1, Sen Lin 2,*, Yajiang Yuan 1,2,*
PMCID: PMC10194113  PMID: 37214286

In the published article, there was an error in Figure 5C as published the authors noticed one error image (SCI group) in Figure 5C. The corrected Figure 5C can be appear below.

FIGURE 5.

FIGURE 5

Anti-inflammation effect of FA-PEG/ZIF-8 in SCI mice. Representative images (A) and quantification analysis (B) of Iba-1 in the spinal cord. Representative images (C) and quantification analysis (D) of Tunel in the spinal cord. Representative images (E) of IL-1β in the spinal cord. Representative images (F) and quantification analysis (G) of IL-1β and cleaved-caspase-3 in the spinal cord via Western blot. Quantification analysis of iNOS (H), IL-1β (I), Arg-1 (J), and IL-10 (K) mRNA levels in the spinal cord. Scale bars, 100 µm. Data are presented as the mean±SD. Two-tailed Student’s t-test.**p < 0.01, ***p < 0.001, ****p < 0.0001.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.


Articles from Frontiers in Bioengineering and Biotechnology are provided here courtesy of Frontiers Media SA

RESOURCES